Geneva Partners’s iShares iBonds Dec 2019 Term Corporate ETF IBDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,158
Closed -$277K 94
2018
Q3
$277K Sell
11,158
-23,497
-68% -$582K 0.21% 79
2018
Q2
$859K Sell
34,655
-7,845
-18% -$194K 0.68% 48
2018
Q1
$1.05M Buy
42,500
+1,000
+2% +$24.8K 0.87% 42
2017
Q4
$1.03M Buy
41,500
+5,130
+14% +$128K 0.77% 49
2017
Q3
$911K Buy
+36,370
New +$910K 0.72% 50
2016
Q2
$851K Buy
+34,000
New +$854K 0.76% 47

Other funds holding IBDK

Geneva Partners's IBDK Position: Q4 2018 in Review

Geneva Partners sold out of iShares iBonds Dec 2019 Term Corporate ETF (IBDK) in Q4 2018, closing a stake of 11,158 shares — an estimated $277K sold.

Geneva Partners first reported a position in IBDK in Q2 2016 and held it in 6 quarters. The position peaked at $1.05M in Q1 2018. 111 funds tracked by Wall St. Rank hold IBDK as of Q4 2018.

  • Geneva Partners reported no remaining iShares iBonds Dec 2019 Term Corporate ETF position as of Q4 2018 after selling out during the quarter.
  • Geneva Partners sold 11,158 iShares iBonds Dec 2019 Term Corporate ETF shares in Q4 2018, an estimated $277K.
  • Geneva Partners first reported a position in iShares iBonds Dec 2019 Term Corporate ETF in Q2 2016 and held it in 6 quarters.
  • Geneva Partners's iShares iBonds Dec 2019 Term Corporate ETF position peaked at $1.05M in Q1 2018.
  • 111 funds tracked by Wall St. Rank held iShares iBonds Dec 2019 Term Corporate ETF as of Q4 2018.

Based on Geneva Partners's 13F filing for Q4 2018, filed 30 Jan 2019.